266 related articles for article (PubMed ID: 33947030)
1. Germline Genetics of Prostate Cancer: Prevalence of Risk Variants and Clinical Implications for Disease Management.
Doan DK; Schmidt KT; Chau CH; Figg WD
Cancers (Basel); 2021 Apr; 13(9):. PubMed ID: 33947030
[TBL] [Abstract][Full Text] [Related]
2. Bringing Prostate Cancer Germline Genetics into Clinical Practice.
Das S; Salami SS; Spratt DE; Kaffenberger SD; Jacobs MF; Morgan TM
J Urol; 2019 Aug; 202(2):223-230. PubMed ID: 30730411
[TBL] [Abstract][Full Text] [Related]
3. Evolving Intersection Between Inherited Cancer Genetics and Therapeutic Clinical Trials in Prostate Cancer: A White Paper From the Germline Genetics Working Group of the Prostate Cancer Clinical Trials Consortium.
Carlo MI; Giri VN; Paller CJ; Abida W; Alumkal JJ; Beer TM; Beltran H; George DJ; Heath EI; Higano CS; McKay RR; Morgans AK; Patnaik A; Ryan CJ; Schaeffer EM; Stadler WM; Taplin ME; Kauff ND; Vinson J; Antonarakis ES; Cheng HH
JCO Precis Oncol; 2018; 2018():. PubMed ID: 30761386
[TBL] [Abstract][Full Text] [Related]
4. Prostate cancer: germline prediction for a commonly variable malignancy.
Bambury RM; Gallagher DJ
BJU Int; 2012 Dec; 110(11 Pt C):E809-18. PubMed ID: 22974436
[TBL] [Abstract][Full Text] [Related]
5. Mutation Detection in Patients With Advanced Cancer by Universal Sequencing of Cancer-Related Genes in Tumor and Normal DNA vs Guideline-Based Germline Testing.
Mandelker D; Zhang L; Kemel Y; Stadler ZK; Joseph V; Zehir A; Pradhan N; Arnold A; Walsh MF; Li Y; Balakrishnan AR; Syed A; Prasad M; Nafa K; Carlo MI; Cadoo KA; Sheehan M; Fleischut MH; Salo-Mullen E; Trottier M; Lipkin SM; Lincoln A; Mukherjee S; Ravichandran V; Cambria R; Galle J; Abida W; Arcila ME; Benayed R; Shah R; Yu K; Bajorin DF; Coleman JA; Leach SD; Lowery MA; Garcia-Aguilar J; Kantoff PW; Sawyers CL; Dickler MN; Saltz L; Motzer RJ; O'Reilly EM; Scher HI; Baselga J; Klimstra DS; Solit DB; Hyman DM; Berger MF; Ladanyi M; Robson ME; Offit K
JAMA; 2017 Sep; 318(9):825-835. PubMed ID: 28873162
[TBL] [Abstract][Full Text] [Related]
6. Ethnic disparities among men with prostate cancer undergoing germline testing.
Kwon DH; Borno HT; Cheng HH; Zhou AY; Small EJ
Urol Oncol; 2020 Mar; 38(3):80.e1-80.e7. PubMed ID: 31630993
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of universal germline testing for men with prostate cancer in an Australian tertiary center.
Crumbaker M; Wong J; Joshua AM; Spigelman AD
Asia Pac J Clin Oncol; 2019 Aug; 15(4):257-261. PubMed ID: 31012270
[TBL] [Abstract][Full Text] [Related]
8. Genetics in prostate cancer: implications for clinical practice.
Szymaniak B; Ross AE; Morgans AK
Curr Opin Support Palliat Care; 2021 Dec; 15(4):241-246. PubMed ID: 34762074
[TBL] [Abstract][Full Text] [Related]
9. Germline genetic variants in men with prostate cancer and one or more additional cancers.
Pilié PG; Johnson AM; Hanson KL; Dayno ME; Kapron AL; Stoffel EM; Cooney KA
Cancer; 2017 Oct; 123(20):3925-3932. PubMed ID: 28657667
[TBL] [Abstract][Full Text] [Related]
10. DNA Damage Repair (DDR) Mutations and the Utility of High-Risk Genetics Clinics in Metastatic Castration-Refractory Prostate Cancer (mCRPC).
Rathi N; Anderson N; Greenberg S; Vagher J; Agarwal N; Hahn AW
World J Oncol; 2018 Aug; 9(4):119-122. PubMed ID: 30220950
[TBL] [Abstract][Full Text] [Related]
11. Germline and Somatic Mutations in Prostate Cancer for the Clinician.
Cheng HH; Sokolova AO; Schaeffer EM; Small EJ; Higano CS
J Natl Compr Canc Netw; 2019 May; 17(5):515-521. PubMed ID: 31085765
[TBL] [Abstract][Full Text] [Related]
12. Germline Genetic Testing for Breast Cancer Risk: The Past, Present, and Future.
Yadav S; Couch FJ
Am Soc Clin Oncol Educ Book; 2019 Jan; 39():61-74. PubMed ID: 31099663
[TBL] [Abstract][Full Text] [Related]
13. Prostate Cancer Screening in a New Era of Genetics.
Cheng HH; Pritchard CC; Montgomery B; Lin DW; Nelson PS
Clin Genitourin Cancer; 2017 Dec; 15(6):625-628. PubMed ID: 28697982
[TBL] [Abstract][Full Text] [Related]
14. DNA Repair in Prostate Cancer: Biology and Clinical Implications.
Mateo J; Boysen G; Barbieri CE; Bryant HE; Castro E; Nelson PS; Olmos D; Pritchard CC; Rubin MA; de Bono JS
Eur Urol; 2017 Mar; 71(3):417-425. PubMed ID: 27590317
[TBL] [Abstract][Full Text] [Related]
15. Intraductal/ductal histology and lymphovascular invasion are associated with germline DNA-repair gene mutations in prostate cancer.
Isaacsson Velho P; Silberstein JL; Markowski MC; Luo J; Lotan TL; Isaacs WB; Antonarakis ES
Prostate; 2018 Apr; 78(5):401-407. PubMed ID: 29368341
[TBL] [Abstract][Full Text] [Related]
16. BRCA Mutations in Prostate Cancer: Prognostic and Predictive Implications.
Messina C; Cattrini C; Soldato D; Vallome G; Caffo O; Castro E; Olmos D; Boccardo F; Zanardi E
J Oncol; 2020; 2020():4986365. PubMed ID: 32963528
[TBL] [Abstract][Full Text] [Related]
17. Genetic testing for hereditary prostate cancer: Current status and limitations.
Zhen JT; Syed J; Nguyen KA; Leapman MS; Agarwal N; Brierley K; Llor X; Hofstatter E; Shuch B
Cancer; 2018 Aug; 124(15):3105-3117. PubMed ID: 29669169
[TBL] [Abstract][Full Text] [Related]
18. Germline Variants in Targeted Tumor Sequencing Using Matched Normal DNA.
Schrader KA; Cheng DT; Joseph V; Prasad M; Walsh M; Zehir A; Ni A; Thomas T; Benayed R; Ashraf A; Lincoln A; Arcila M; Stadler Z; Solit D; Hyman DM; Zhang L; Klimstra D; Ladanyi M; Offit K; Berger M; Robson M
JAMA Oncol; 2016 Jan; 2(1):104-11. PubMed ID: 26556299
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic implications of germline genetic findings in cancer.
Thavaneswaran S; Rath E; Tucker K; Joshua AM; Hess D; Pinese M; Ballinger ML; Thomas DM
Nat Rev Clin Oncol; 2019 Jun; 16(6):386-396. PubMed ID: 30783251
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]